COMMUNIQUÉS West-GlobeNewswire
-
Vaccinex to Report New Biomarker Data and Plans for Phase 2B Clinical Trial of Pepinemab in AD at the Alzheimer’s Association International Conference in London on July 13, 2026
08/07/2026 -
FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months
08/07/2026 -
Polomar Health Services Strengthens Board Leadership to Support Standalone Growth Strategy
08/07/2026 -
Nordic Ranked No. 1 Overall in Black Book’s 2026 Healthcare IT Consulting and Advisory Services Report
08/07/2026 -
Cannara to Announce Fiscal Q3 2026 Financial Results on July 15, 2026
08/07/2026 -
Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026
08/07/2026 -
As America Celebrates its 250th Birthday, Becoming Independent Marks 59 Years of Helping People Live on Their Own Terms
08/07/2026 -
Conavi Medical Announces JSCAI Publication Demonstrating the Clinical Utility of Hybrid IVUS OCT Imaging
08/07/2026 -
Seres Therapeutics Announces Early Clinical Data Showing Potential for SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC), a Frequent Adverse Reaction That Forces Many Patients to Halt Cancer Treatment
08/07/2026 -
Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis
08/07/2026 -
Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors
08/07/2026 -
Angelini Ventures Invests in Handspring Health's $19 Million Series B to Expand Access to High-Quality Mental Health Care for Children and Families
08/07/2026 -
Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nominees
08/07/2026 -
Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
08/07/2026 -
Pasithea Therapeutics Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
08/07/2026 -
BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration Capabilities
08/07/2026 -
Shopify to Announce Second-Quarter 2026 Financial Results
08/07/2026 -
Nonprofit Launches One of the Nation’s Most Comprehensive Education Resources for Inherited Retinal Diseases
08/07/2026 -
Upfront Diagnostics Announces Global Medical Advisory Board to Accelerate Efforts in Reducing Time to Stroke Care
08/07/2026
Pages